Future of Neuroscience Conference
The Future of Neuroscience Conference: Implications of ADNI for Treatment, will be presented Friday, April 15, 2011, from 9:00 a.m. to 5:00 p.m.
The program's faculty will discuss the role of neuroimaging measures and other biomarkers in describing subjects with normal aging, mild cognitive impairment (MCI) and Alzheimer's disease and in predicting progression from normal cognition to MCI and from MCI to Alzheimer's disease.
Tentative Schedule
| 9:00 a.m.–9:15 a.m. | Introduction / Ronald Petersen, PhD, MD, Mayo Clinic |
| 9:15 a.m.–10:00 a.m. | Clinical Core Considerations / Ronald C. Petersen, PhD, MD, Mayo Clinic |
| 10:00 a.m.–10:45 a.m. | Break and Posters |
| 10:45 a.m.–11:15 a.m. | Abstract Presentations / TBD |
| 11:15 a.m.–12:00 p.m. | Candidate Genes, Pathways, and GWAS of Quantitative ADNI Phenotypes / Andrew Saykin, PsyD, Indiana University |
| 12:00 p.m.–1:00 p.m. | Luncheon |
| 1:00 p.m.–1:45 p.m. | MRI Core / Charles DeCarli, MD, FAAN, University of California, Davis |
| 1:45 p.m.–2:30 p.m. | PET Imaging Using FDG and Amyloid Tracers / Norman Foster, MD, FAAN, University of Utah |
| 2:30 p.m.–3:15 p.m. | Break and Posters |
| 3:15 p.m.–4:00 p.m. | Abstract Presentations / TBD |
| 4:00 p.m.–4:50 p.m. | Biomarkers in the CSF and Blood / Douglas Galasko, MD, University of California, San Diego |
| 4:50 p.m.–5:00 p.m. | Questions and Answers |